Carboxyamidotriazole
Carboxyamidotriazole[edit | edit source]
Carboxyamidotriazole (CAI) is a small molecule inhibitor that has been studied for its potential use in cancer therapy. It is known for its ability to interfere with calcium signaling pathways, which are crucial for various cellular processes, including cell proliferation, angiogenesis, and metastasis.
Mechanism of Action[edit | edit source]
Carboxyamidotriazole functions primarily by inhibiting non-voltage-operated calcium channels in the cell membrane. This inhibition leads to a decrease in intracellular calcium levels, which in turn affects several downstream signaling pathways. The reduction in calcium influx can inhibit the activation of protein kinase C and other calcium-dependent enzymes, ultimately leading to reduced cell proliferation and angiogenesis.
Therapeutic Applications[edit | edit source]
Carboxyamidotriazole has been investigated for its potential use in treating various types of cancer, including breast cancer, lung cancer, and glioblastoma. Its ability to inhibit angiogenesis makes it a promising candidate for anti-cancer therapy, as it can potentially starve tumors of their blood supply, thereby inhibiting their growth and spread.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of Carboxyamidotriazole involves its absorption, distribution, metabolism, and excretion. CAI is known to have a relatively long half-life, which allows for sustained inhibition of calcium channels. It is metabolized in the liver and excreted primarily through the kidneys.
Side Effects[edit | edit source]
As with many anti-cancer agents, Carboxyamidotriazole can have side effects. Commonly reported side effects include nausea, fatigue, and dizziness. More severe side effects may include hepatotoxicity and nephrotoxicity, which require careful monitoring during treatment.
Research and Development[edit | edit source]
Research on Carboxyamidotriazole is ongoing, with several clinical trials conducted to evaluate its efficacy and safety in cancer patients. Studies have shown that CAI can be used in combination with other chemotherapeutic agents to enhance its anti-cancer effects.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
